Therapeutic effects and mechanisms of N-(9,10-anthraquinone-2-ylcarbonyl) xanthine oxidase inhibitors on hyperuricemia
Objective: To observe the antioxidative effects of N-(9,10-anthraquinone-2-ylcarbonyl) xanthine oxidase inhibitors (NAY) in vitro and in vivo models of hyperuricemia and explore the mechanism.Methods: A classical experimental method of acute toxicity and a chronic toxicity test were used to compare...
Saved in:
Main Authors: | Tianshu Gao (Author), Jin Xu (Author), Yuxiao Xiao (Author), Jiaqi Li (Author), Weifeng Hu (Author), Xiaoyu Su (Author), Xudong Shen (Author), Wan Yu (Author), Zhen Chen (Author), Baosheng Huang (Author), Honglei Li (Author), Xing Wang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anti-hyperuricemia effect of hesperetin is mediated by inhibiting the activity of xanthine oxidase and promoting excretion of uric acid
by: Meng-Fei An, et al.
Published: (2023) -
Xanthine oxidase inhibitors treatment or discontinuation effects on mortality: evidence of xanthine oxidase inhibitors withdrawal syndrome
by: Masanari Kuwabara, et al.
Published: (2024) -
Xanthine oxidase and aldehyde oxidase contribute to allopurinol metabolism in rats
by: Yoshitaka Tayama, et al.
Published: (2022) -
Side Effects and Interactions of the Xanthine Oxidase Inhibitor Febuxostat
by: Andreas Jordan, et al.
Published: (2018) -
Structure-activity relationships of fraxamoside as an unusual xanthine oxidase inhibitor
by: Rosa Maria Vitale, et al.
Published: (2017)